Going head-to-head with Merck on I/O, Genentech vets raise fresh round and enter clinic

Three years after convincing two ex-Genentech colleagues to join her on a hunt of a new form of immuno-oncology, Charlene Liao and her startup, Immune-Onc, are in the clinic and armed with a new round of cash to push the lead candidate through.

Immune-Onc announced on Tuesday $73 million...

Click to view original post